Steriline, the Italian manufacturer renowned for its complete aseptic processing lines for injectable and ophthalmic products, has introduced a compact, next-generation filling and capping machine that combines cutting-edge technology with a flexible design — ideal for cell and gene therapies.
At the heart of this innovation is the RVFCM11-S, an ultra-compact robotic unit (2.25 x 1.65 m) that integrates magnetic levitation, robotic handling, and a double-wall isolator system. The machine exemplifies Steriline’s “zero-loss philosophy”, offering features that help pharmaceutical manufacturers increase efficiency while minimizing waste and maintaining compliance with stringent regulatory requirements.
This highly automated solution is capable of processing up to 15 units per minute — whether bottles, syringes, or nested carpules — with a seamless decontamination process using vaporised hydrogen peroxide (VHP), allowing for quick and safe batch changes. Notably, it also enables the re-processing of containers that fall outside predefined specifications, ensuring optimal yield and product safety.
No-contact handling is achieved through magnetic levitation and robotics, which eliminates friction and the generation of particles — a key consideration in sterile environments. Every stage of the process, from filling to crimping and sealing, is managed by two Stericlean robots, ensuring precise, individual handling of each container without any glass-to-glass contact.
An integrated weight control system ensures dosing accuracy, while the ring-sealing phase is monitored using artificial vision, guaranteeing a secure and consistent closure.
This launch confirms Steriline’s strategic focus on innovation and flexibility. With more than 2,000 machines installed globally and exports accounting for over 90% of its revenue, Steriline continues to set benchmarks in the field of aseptic processing.